methotrexate (MTX)
M14-496
Approved small_molecule completed
Quick answer
methotrexate (MTX) for Psoriatic Arthritis is a Approved program (small_molecule) at AbbVie with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie
- Indication
- Psoriatic Arthritis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed